v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities    
Net income $ 85,700 $ 25,204
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 16,247 16,117
Loss on disposal of property, plant and equipment 367 15
Stock-based compensation 40,806 32,700
Deferred income taxes (11,599) (13)
Noncash lease expense 2,088 2,289
Revaluation of acquisition-related contingent consideration (1,110) (2,713)
Effect of foreign currency on operations (23) (3,845)
Amortization of discount on short-term investments (2,380) (2,619)
Impairment loss 0 20,505
Non-cash loss on deconsolidation of subsidiary 0 3,863
Changes in operating assets and liabilities:    
Accounts receivable (11,963) (3,858)
Supplies (3,435) (2,642)
Prepaid expenses and other current assets (4,112) (6,416)
Other assets (771) 331
Operating lease liabilities 496 (1,681)
Accounts payable 5,522 (547)
Accrued liabilities and deferred revenue 5,466 7,034
Net cash provided by operating activities 121,299 83,724
Investing activities    
Business acquisitions, net of cash acquired (153,190) 0
Purchase of short-term investments (234,997) (99,998)
Proceeds from maturity of short-term investments 116,984 102,116
Issuance of loan receivable (1,622) 0
Purchases of property, plant and equipment (8,155) (5,897)
Net cash used in investing activities (280,980) (3,779)
Financing activities    
Payment of taxes on vested restricted stock units (17,462) (14,645)
Proceeds from the exercise of common stock options and employee stock purchases 14,493 10,572
Net cash used in financing activities (2,969) (4,073)
(Decrease) increase in cash, cash equivalents and restricted cash (162,650) 75,872
Effect of foreign currency on cash, cash equivalents and restricted cash (102) 707
Net (decrease) increase in cash, cash equivalents and restricted cash (162,752) 76,579
Cash, cash equivalents and restricted cash at beginning of period 364,226 240,631
Cash, cash equivalents and restricted cash at end of period 201,474 317,210
Supplementary cash flow information:    
Purchases of property, plant and equipment included in accounts payable and accrued liability 2,250 828
Cash paid for tax 2,467 2,388
Deferred purchase consideration recognized in connection with business acquisition $ 6,000 $ 0